EGFR and atrial fibrillation: For example, the effect of ibrutinib on atrial fibrillation is caused by its off-target inhibition of CSK (Xiao et al., 2020), while the skin toxicities of ibrutinib likely involve its inhibition of EGFR as the symptoms overlap with those caused by selective EGFR inhibitors (Singer et al., 2019).